Will the routine use of high dose steroids for alcoholic hepatitis result in an increased incidence of clinically significant hypocortisolism in patients with liver cirrhosis?
Priya Karia, Vassiliki Bravis, Victoria Salem, Shiva Radhakrishnan, Dri Choa
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Priya Karia, Vassiliki Bravis, Victoria Salem, Shiva Radhakrishnan, Dri Choa. "Will the routine use of high dose steroids for alcoholic hepatitis result in an increased incidence of clinically significant hypocortisolism in patients with liver cirrhosis?." Endocrine Abstracts (2016)